Urinary And Breast Milk Biomarkers To Assess Exposure Ro Naphthalene In Pregnant Women: An Investigation Of Personal And Indoor Air Sources by Wheeler, Amanda J et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
1-1-2014 
Urinary And Breast Milk Biomarkers To Assess Exposure Ro 
Naphthalene In Pregnant Women: An Investigation Of Personal 
And Indoor Air Sources 
Amanda J. Wheeler 
Edith Cowan University, a.wheeler@ecu.edu.au 
Nina A. Dobbin 
Marie-Eve Heroux 
Mandy Fisher 
Liu Sun 
See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Medicine and Health Sciences Commons 
10.1186/1476-069X-13-30 
Wheeler, A. J., Dobbin, N., Heroux, M., Fisher, M., Sun, L., Khoury, C., Hauser, R., Walker, M., Ramsay, T., Bienvenu, J., 
LeBlanc, A., Daigle, E., Gaudreau, E., Belanger, P., Feeley, M., Ayotte, P., & Arbuckle, T. (2014). Urinary and breast milk 
biomarkers to assess exposure to naphthalene in pregnant women: an investigation of personal and indoor air 
sources. Environmental Health: A Global Access Science Source, 13(1), Article 30. Available here 
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) 
applies to the data made Available in this article, unless otherwise stated. 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/555 
Authors 
Amanda J. Wheeler, Nina A. Dobbin, Marie-Eve Heroux, Mandy Fisher, Liu Sun, Cheryl F. Khoury, Russ 
Hauser, Mark Walker, Tim Ramsay, Jean-Francois Bienvenu, Alain LeBlanc, Eric Daigle, Eric Gaudreau, 
Patrick Belanger, Mark Feeley, Pierre Ayotte, and Tye E Arbuckle 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/555 
RESEARCH Open Access
Urinary and breast milk biomarkers to assess
exposure to naphthalene in pregnant women: an
investigation of personal and indoor air sources
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Russ Hauser3, Mark Walker4, Tim Ramsay4, Jean-François Bienvenu5, Alain LeBlanc5, Éric Daigle5, Eric Gaudreau5,
Patrick Belanger5, Mark Feeley6, Pierre Ayotte5,7 and Tye E Arbuckle2
Abstract
Background: Naphthalene exposures for most non-occupationally exposed individuals occur primarily indoors at
home. Residential indoor sources include pest control products (specifically moth balls), incomplete combustion
such as cigarette smoke, woodstoves and cooking, some consumer and building products, and emissions from
gasoline sources found in attached garages. The study aim was to assess naphthalene exposure in pregnant women
from Canada, using air measurements and biomarkers of exposure.
Methods: Pregnant women residing in Ottawa, Ontario completed personal and indoor air sampling, and
questionnaires. During pregnancy, pooled urine voids were collected over two 24-hour periods on a weekday and
a weekend day. At 2–3 months post-birth, they provided a spot urine sample and a breast milk sample following
the 24-hour air monitoring. Urines were analyzed for 1-naphthol and 2-naphthol and breast milk for naphthalene.
Simple linear regression models examined associations between known naphthalene sources, air and biomarker
samples.
Results: Study recruitment rate was 11.2% resulting in 80 eligible women being included. Weekday and weekend
samples were highly correlated for both personal (r = 0.83, p < 0.0001) and indoor air naphthalene (r = 0.91,
p < 0.0001). Urine specific gravity (SG)-adjusted 2-naphthol concentrations collected on weekdays and weekends
(r = 0.78, p < 0.001), and between pregnancy and postpartum samples (r = 0.54, p < 0.001) were correlated.
Indoor and personal air naphthalene concentrations were significantly higher post-birth than during pregnancy
(p < 0.0001 for signed rank tests); concurrent urine samples were not significantly different. Naphthalene in breast
milk was associated with urinary 1-naphthol: a 10% increase in 1-naphthol was associated with a 1.6% increase in
breast milk naphthalene (95% CI: 0.2%-3.1%). No significant associations were observed between naphthalene
sources reported in self-administered questionnaires and the air or biomarker concentrations.
Conclusions: Median urinary concentrations of naphthalene metabolites tended to be similar to (1-naphthol) or
lower (2-naphthol) than those reported in a Canadian survey of women of reproductive age. Only urinary
1-naphthol and naphthalene in breast milk were associated. Potential reasons for the lack of other associations
include a lack of sources, varying biotransformation rates and behavioural differences over time.
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Background
Naphthalene is an abundant polycyclic aromatic hydro-
carbon (PAH) found in urban environments. It is typic-
ally present in the gas-phase under usual ambient
conditions and is routinely detected in both indoor and
outdoor environments. Most naphthalene exposures for
non-occupationally exposed individuals occur primarily
indoors at home [1]. US ATSDR considers naphthalene
as reasonably anticipated to be a human carcinogen [2]
while IARC has classified naphthalene as a possible hu-
man carcinogen (Group 2B) [3]. Health Canada’s long-
term (≥24-hour) maximum exposure limit for residential
naphthalene indoor air concentrations is 10 μg/m3 [4].
There are a number of known naphthalene indoor
sources and these include pest control products, (i.e.,
moth balls), incomplete combustion such as cigarette
smoke, woodstoves and cooking, as well as some con-
sumer and building products [1,5-7]. Indoor naphthalene
concentrations have also been shown to be elevated in
homes with smokers versus homes without smokers [8,9]
and can off-gas and volatilize from vehicles and stored
petroleum products found in attached garages [9-11].
Outdoor sources of naphthalene include exhaust from
vehicles, including diesel and gas-powered equipment, as
well as vapours from petroleum products. Other sources
that are less common include asphalt, forest fires and
some industrial processes [9,12,13].
To understand total human exposure to naphthalene a
limited number of studies have included both personal
air sampling along with biomonitoring [14,15]. Uptake,
absorption, distribution, and metabolism can be affected
by individual physiological differences and behaviours
[14]. The overall rate of metabolism of naphthalene by
humans is unknown, although it has been suggested that
there is a two-phase excretion of 1-naphthol in urine.
The first phase exhibits a half-life of approximately 1.2 –
1.9 hours while the second phase is 14 – 46 hours [16].
Naphthalene is metabolically activated by forms of cyto-
chrome P450 to naphthalene 1,2-oxide, which can be de-
toxified by glutathione-Ѕ-transferase (GST) to eventually
be excreted as mercapturic acids in urine or spontan-
eously convert to 1- and 2-naphthol and be eliminated
in the urine as glucuronides and sulfates. Naphthalene
1,2-oxide can also undergo other transformations to
dihydroxydimethylthio and trihydroxymethylthio metab-
olites and trihydroxymercapturic acid in urine [17].
Biomonitoring can provide insight into the uptake of
naphthalene. Only a few studies [18-20] have attempted
to measure naphthalene in breast milk and to date, there
are no Canadian data available. Conjugates of 1-naphthol
and 2-naphthol in urine have been associated with pre-
dicted concentrations in the breathing zone but there are
limited data available in non-occupationally exposed indi-
viduals [14]. Meeker et al. [21] recommended that the
ratio of 1-naphthol to 2-naphthol be used to identify the
metabolism of naphthalene. They identified situations
where discrepancies between concentrations of these metab-
olites (e.g., ratio >2) were in fact related to the metabolism
of the insecticide carbaryl (1-naphthyl methylcarbamate)
which is primarily excreted as 1-naphthol.
As pregnancy is associated with a number of physio-
logical changes in women that could affect the toxicoki-
netics of chemicals [22] and there are critical periods of
development during pregnancy for the fetus, it is im-
portant to study the exposure of pregnant women to po-
tentially harmful chemicals such as naphthalene. Reports
of probable fetal exposure after maternal inhalation or
ingestion of naphthalene have been documented in the
scientific literature [22,23]. Infants, particularly those
with a glucose-6-phosphate dehydrogenase (G6PD) defi-
ciency, may be particularly sensitive to naphthalene ex-
posure. Cases of hemolytic anemia, sometimes leading
to more serious outcomes (e.g., kernicterus (irreversible
neurological impairment) and death), have been reported
in infants exposed to naphthalene-treated household
items [24-32]. Authors of a recently published New York
study of 5-year old children’s urinary naphthalene metabol-
ite concentrations identified an association with chromo-
somal aberrations (including translocations) which are
precancerous changes in adults [33].
We conducted a cohort study in a group of pregnant
women residing in Ottawa, Ontario, Canada to assess
naphthalene exposure and biomarkers in maternal urine
and breast milk. We assessed naphthalene sources and
concentrations inside residences, along with personal ex-
posure measures, to assist in determining both source
and route-specific information related to naphthalene
exposure in a non-occupationally exposed population.
This study addresses current knowledge gaps by attempt-
ing to measure naphthalene body burdens, identify major
sources of naphthalene exposure, and quantify their con-
tribution to an individual’s exposure.
Methods
Pregnant women (<20 weeks gestation) from the Ottawa
area were recruited to participate in the P4 Study: Plastics
and Personal-care Product Use in Pregnancy, a wider study
investigating pregnant women’s exposure to a range of che-
micals. This manuscript focusses on the personal and in-
door air exposure to naphthalene and resulting biomarkers.
Recruitment was clinic-based and occurred at an obstet-
rical clinic at The Ottawa Hospital (TOH) and a privately
run obstetrical clinic. Posters and pamphlets about the
study were placed in the obstetrical and ultrasound clinics
of TOH and physician offices. Research nurses from the
clinical sites were trained in patient screening, recruitment,
obtaining consent, specimen and data collection, and
processing, as well as the shipment of biospecimens.
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The women completed detailed consumer product
diaries along with noting any use of products containing
naphthalene for a 48-hour period during the early preg-
nancy visits and 24-hours prior to the post-partum visit.
Typically the biomarker and air collection started at the
midpoint of the diary, i.e. 24-hours after the start of the
diary.
Biomarker collection and analysis
For the purposes of this analysis, the women provided
urine samples on three occasions: twice during pregnancy
(<20 weeks) and once at two to three months post-birth.
In order to assess activity related differences in exposure,
prior to 20 weeks of pregnancy women were asked to col-
lect all voids over two 24-hour periods (multiple spot
urines) – once on a week day and again on a weekend day.
After collection, a small equal amount from each void dur-
ing the 24-hour period was pooled to create an aggregated
sample for naphthalene biomarker analysis. At two to
three months post-birth, the women provided a single
spot urine sample at the end of the 24-hour air monitoring
period. These samples were stored at −20°C until analyses.
One paper has reported that 1- and 2-naphthol in urine
was stable for at least 1 month at −20°C [34].
Analyses of 1-naphthol and 2-naphthol were undertaken
on the 24-hour aggregated pregnancy urine samples and
the post-birth spot sample using the following method. In-
ternal standards (1-naphthol-d7 and 2-naphthol-d7) were
added to a 1 mL volume of urine. The conjugated forms
of 1-naphthol and 2-naphthol were hydrolyzed at 37°C
for 16 hours with β-glucuronidase (helix pomatia). The
extraction of the analytes was performed on a mixed
mode solid-phase extraction (SPE) cartridge Oasis
MAX (Waters), 60 mg. The analytes were eluted with
methanol, dried and reconstituted in 200 μL of a mix-
ture of mobile phase A and B (72:28) containing gallic
acid (200 mg/L). The extracts were analyzed by UPLC-
MS-MS (Acquity UPLC system and Xevo TQ-S tandem
mass spectrometer, Waters; Milford, MA). The LC sep-
aration was performed on a Halo C18 column (2.1 ×
50 mm, 2.7 μm, Advanced Materials Technology) with
0.01% NH4OH in water as mobile phase A and aceto-
nitrile as mobile phase B. The separation was achieved
isocratically with 28% of B over 3.5 minutes, and the
column was flushed with 100% B for 0.3 minutes at a flow
rate of 0.5 mL/min. The total run time was 4 minutes.
The limits of detection for 1-naphthol and 2-naphthol
were 0.03 μg/L, and the calibration curves were linear up
to 50 μg/L. Field blanks for the urinary samples were ana-
lyzed and no contamination was found. The analytes were
monitored by Multiple Reaction Monitoring (MRM) in
the negative mode for the following ions: 1-naphthol and
2-naphthol : m/z 143.0 > 115.1 (quantifier) and 143.0 >
143.0 (qualifier)1-naphthol-d7 and 2-naphthol-d7 : m/z
150.0 > 122.1 (quantifier) and 150.0 > 150.0 (qualifier).
Quality control (QC) materials, including method ana-
lytical blanks, were prepared from human urine obtained
from volunteers in the analytical laboratory. The urine,
previously tested for 1- and 2-naphthol content, was
spiked, with a solution of 1- and 2-naphthol from a dif-
ferent supplier, at a concentration of 20 μg/L to obtain a
high concentration QC material. The low concentration
QC material was composed of the unchanged urine
(concentrations: 1.0 μg/L for 1-naphthol and 0.5 μg/L
for 2-naphthol). The two QC materials were used in
alternation and placed after each set of ten samples in
each analytical batch. The INSPQ laboratory participates
in the German external quality assessment scheme (http://
www.g-equas.de/) in which 1- and 2-naphthol are assayed.
As concentrations derived from urine may be affected
by the dilution of the urine, concentrations were corrected
by the specific gravity (SG) of the sample. The following
formula was used (adapted from Just et al., [35]):
Pc = Pi [(SGm– 1)/(SGi – 1)], where Pc is the specific
gravity-adjusted metabolite concentration (ng /mL), Pi is
the observed metabolite concentration, and SGi is the spe-
cific gravity of the urine sample and SGm is the median
specific gravity for the cohort.
Breast milk was collected at the two to three month
post-birth visit, at the end of the 24-hour air monitoring
period. The breast milk sample was collected by either
hand or pump in a glass container, kept cool until deliv-
ered to the laboratory where it was transferred to 30 mL
Nalgene® containers and stored at −20°C until analysis as
per methods described by other studies [19,20]. Breast
milk was analyzed for naphthalene using the following
method. Briefly, the internal standard (naphthalene-d8)
was added to a 1 mL volume of breast milk. The extrac-
tion of naphthalene was performed with a silicone/PFTE
septum, by heating at 80°C for 16 hours. The septum
was transferred into a headspace vial, incubated at
145°C for 5 minutes and injected by the headspace
technique on a GC-MS-MS (7890A gas chromato-
graph with 7000B tandem mass spectrometer, Agilent
Technologies; Mississauga, Ontario, Canada) equipped
with a PAL Combi-xt injector (Leap Technologies;
Carrboro, NC, USA). The GC separation was achieved
on a DB-5 ms column (30 m × 0.25 mm × 0.25 μm,
Agilent Technologies). The temperature of the injector
was 250°C and the temperature gradient was: Initial
temperature of 100°C for 0.5 minutes, then 40°C/minute
until 320°C, then hold for 2 minutes. Carrier gas was
helium at a flow rate of 2 mL/min. The limit of detec-
tion for naphthalene was 0.03 μg/L. The analytes were
monitored by Multiple Reaction Monitoring (MRM) in
the positive mode for the following ions:naphthalene :
m/z 128 > 128 (quantifier) and 128 > 102 (qualifier)
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naphthalene-d8 : m/z 136 > 136 (quantifier) and 136 >
108 (qualifier).
Quality control (QC) materials, including method ana-
lytical blanks, were prepared from human milk obtained
from volunteers in the analytical laboratory. The milk,
previously tested for naphthalene content, was spiked
with a solution of naphthalene from a different supplier,
at a concentration of 10 μg/L to obtain a high concen-
tration QC material, and a concentration of 0.4 μg/L to
obtain a 0.5 μg/L low concentration QC material. The
two QC materials were used in alternation and placed
after each set of ten samples in each analytical batch.
While no studies on the stability of naphthalene in milk
stored at −20°C could be found in the literature, one study
has reported naphthalene contamination from packaging
materials of milk samples stored at room temperature in
low-density polyethylene containers [36]. However, our
breast milk was collected in glass jars, kept refrigerated
until aliquoted in the laboratory into Nalgene® containers
and immediately frozen at −20°C. The Mendela® breast
pump provided to participants was tested and no naphtha-
lene was detected.
As naphthalene is fat soluble and concentrations are
affected by the lipid concentrations in an individual’s
breast milk, the naphthalene concentrations were cor-
rected for lipid concentration and are reported in ng/g
lipid.
Air monitoring and analysis
Personal and indoor air measures of naphthalene were
completed concurrently with the 24-hour urine collection
and prior to the spot urine and breast milk collection. Per-
sonal air monitoring was completed in the women’s
breathing zone by attaching the sampler to their collar,
while indoor air monitoring required the women to place
a sampler in their living rooms at a height of approxi-
mately 1.5 m, away from any sources of heat. Each passive
sampler measured 24-hour air samples for naphthalene
(OVM 3500, 3 M, St. Paul, MN). As the air monitoring
was participant-based, replicate sampling was not
attempted due to the complexity of conducting this
additional monitoring.
Naphthalene was extracted using toluene, which was
previously demonstrated to have a recovery of 72%. The
analysis protocol has been described previously [37].
Briefly, this involved extracting the samples with 2 mL of
toluene for one hour on a mechanical shaker. The toluene
extraction solvent was spiked with 1,2-dichlorobenzene-d4
(1.34 ng/μL). The extraction solvent was then transferred
to a 1.5 mL autosampler vial and analyzed via GC-MS
(HP5890 II GC & HP5792 MS). The GC was equipped
with a capillary column (J&W 123–1364 DB-624, 60 m ×
0.32 mm × 1.8 μm). The carrier gas (helium) head pres-
sure was 6.0 PSI and injector and detector temperatures
were kept constant at 220°C and 260°C, respectively. The
temperature program yielded a 12.9 min retention time
(initial temperature, 80°C for 1 min, 80°C to 260°C at
15°C/min, hold for 1.5 min). The MS was configured to
quantify the following 3 characteristic ions of naphtha-
lene: 128, 102 and 64 amu. The ion ratios and peak inte-
gration were verified manually for each sample.
The naphthalene concentrations were calculated using
the mass adsorbed on each sampler, the specific uptake
rate for naphthalene, exposure times to the nearest one
minute and laboratory blank PSDs analyzed at the same
time as the samples. The method detection limit (MDL),
including handling and extraction was determined by
the CFR 40 method. The MDL was 0.1 μg/m3 [37].
To calculate concentrations, the laboratory results were
merged with log sheet data. Concentrations were calcu-
lated based on sample mass, sampling duration, sampling
rate and recovery efficiency. All samples were coded as
valid, flagged, or invalid, based on the sampling period and
field technician comments. Samples with a sampling
period ± 25% of the target duration (24-hours) were
deemed invalid. If the sampling period was ± 12.5 to
25%, the samples were flagged. Samples with technician
comments such as container not sealed on time, un-
known sampling location, were also flagged.
Statistical methods
Given the naphthalene exposures were not normally dis-
tributed, Spearman correlations were conducted to deter-
mine correlations between the air and urine naphthalene
measurements within visits and across visits. The non-
parametric signed rank test was used to test differences
between levels measured at different visits. Intra-class cor-
relation coefficients (ICC) were calculated using a one way
random effects model (Proc Mixed) on air and biomarker
concentrations that were transformed using the natural
logarithm. ICC measures the ratio of between-subject
variance to total variance ranging from 0 (meaning no
within person reproducibility) to 1 (meaning perfect re-
producibility). We defined 0.75 as high; 0.40 to 0.75 as
moderate; below 0.40 as poor reproducibility [38]. Simple
linear regression models were used to examine associa-
tions between a number of known naphthalene sources
and measured concentrations in log transformed air and
biomarker samples. As there were no significant differ-
ences between air or urinary biomarker concentrations
measured on the weekday and weekend pregnancy visit,
these were averaged for the pregnancy models; separate
models were created for the pregnancy and the post-
partum visits.
The independent variables examined were: age, body
mass index (BMI) (calculated from pre-pregnancy weight),
season, moth ball use, exposure to smoke (current smoker,
previously a smoker, exposure to second hand smoke
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(SHS) and exposure to SHS in the home), exposure to
traffic pollutants including the presence of an attached
garage, density of roads and highways in neighbourhood
(total road or expressway segment length in a participant’s
3-digit postal code divided by the area of the 3-digit postal
code), exposure to indoor combustion (presence of wood-
burning fireplace), and type of ventilation and heating in
the home. Naphthalene in indoor and personal air, 1-
naphthol and 2-naphthol in urine, and naphthalene in
breast milk were examined as the dependent variables in
turn. In biomarker models, personal and indoor air naph-
thalene concentrations were also entered as independent
predictors in turn.
Since 1-naphthol in urine can also originate from expos-
ure to carbaryl, we examined the ratio of 1-naphthol to 2-
naphthol as an indicator of its source. Ratios above 2 may
indicate that a portion of the 1-naphthol originated from
carbaryl rather than naphthalene exposure [21,39]. Where
this occurred, a sensitivity analysis excluding these individ-
uals was conducted. All data processing and analyses were
conducted using SAS Enterprise Guide 4.2 (SAS Institute,
Inc.).
Results
A total of 1307 potential research participants were
approached to enter the study from November 2009 to
December 2010. 769 potential participants were eligible
for the study of whom 86 were recruited during this
time period, with an acceptance rate of 11.2%. The rea-
sons for the low recruitment included significant partici-
pant burden, no interest in participating, too busy, and
unease about wearing the air monitors in public. There
were a total of 86 participants recruited, six participants
agreed to participate and signed the consent form but
then shortly afterwards withdrew leaving 80 participants
who completed the first visit in early pregnancy. 70 partic-
ipants completed visit 2, 71 completed visit 3, 73 had com-
pleted chart reviews at delivery and 63 completed the final
post-partum visit. A total of 7 participants withdrew from
the study, 7 were lost to follow-up and three had early out-
comes (miscarriage, stillbirth, neonatal death). Initially
recruitment of the women was aimed at before the 14th
week of pregnancy; however, this had to be expanded to
include the window of 19 weeks 6 days gestation in the
winter of 2010 due to low recruitment as women seemed
hesitant to participate early in pregnancy. This change
dramatically increased recruitment.
Table 1 includes details of the participant characteris-
tics. The average age of participants at time of delivery
was 33 years, with a range from 20 to 47 years. This was
the first pregnancy for 37 of the participants. Fifty-five
percent of the participants had a household income ex-
ceeding $100,000CDN and 89% had a college or university
degree.
For the air monitoring component, a total of 375 par-
ticipant days were completed. These included 322 valid
samples, 28 flagged samples due to sampling times being
12.5 to 25% greater or less than the targeted 24-hours,
24 invalid samples due to sampling times being beyond
the targeted 24-hours ± 25% or due to damage of the
sampler, and 1 sample below detection. Blank correc-
tions were not required as no blanks had detectable con-
centrations of naphthalene. There were no duplicates
collected due to the complexity of having participants
complete their own data collection.
A total of 191 urine samples (all samples were in-
cluded from both of the pregnancy visits) were analyzed
for 1-napthol and 2-napthol (62 from weekday and 67
from weekend visits during pregnancy, and 62 from the
Table 1 Characteristics of the study population
Participant characteristics and
exposures*
Frequency (%) or mean (SD)
(N = 80)
Age (years) 32.4 ± 5.0
BMI (Kg/m2) 24.0 ± 4.3
Education level – college/university
degree
71 (89)
Household income Below $50 k 4 (5)
Above $100 k 44 (55)
Parity Primiparous 37 (46)
Multiparous 43 (54)
Ever smoked more than 100 cigarettes 25 (32)
Smoke currently 2 (3)
Exposed to second hand smoke 18 (23)
Exposed to second hand smoke inside
home
3 (4)
Road density in postal code (km/km2) 2.03 ± 1.32
Highway density in postal code
(km/km2)
0.41 ± 0.37
Home Characteristics# Pregnancy(N = 56)
Post-birth
(N = 53)
Moth balls used 5 (9%) 0 (0%)
House with an attached garage and
connecting door
25 (45%) 24 (45%)
Fireplace 33 (59%) 33 (62%)
Wood 16 (29%) 13 (25%)
Natural gas 14 (25%) 17 (32%)
Heating type
Electric 3 (5%) 6 (11%)
Natural gas 46 (82%) 39 (74%)
Oil 4 (7%) 6 (11%)
*Participant characteristics were asked at the pregnancy visit only.
#Home characteristic questionnaires were not filled out by all participants in
each phase of the study. The total number filled out in each period is given in
brackets. Models examining these variables were limited to participants with
reported data.
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post-delivery visit). Fifty-two breast milk samples were
analysed for naphthalene.
Descriptive statistics for the naphthalene in air and
breast milk, and the biomarker urinary metabolites are
presented in Table 2. Results for the urinary biomarkers
are presented with and without adjustment for specific
gravity (SG), which accounts for differences in individual
hydration status. SG-adjusted geometric mean urinary
concentrations tended to be higher than the correspond-
ing unadjusted concentrations. Median SG-adjusted urin-
ary concentrations of 1-naphthol collected on a weekday
and weekend day were 1.19 and 1.15 μg/L, respectively.
SG-adjusted median concentrations of 2-naphthol in urine
varied from 2.53 to 3.33 μg/L, depending on when the
sample was collected. Concentrations of SG-adjusted 1-
and 2-napthol in urine did not significantly differ between
the three collection periods.
Indoor and personal air naphthalene concentrations
did not significantly differ between the weekday and
weekend visits (Table 2). However, both indoor and per-
sonal air measurements were significantly higher at the
post-partum visit than at the pregnancy visits (p < 0.0001
for signed rank tests). The air samples were analysed
throughout the course of the data collection with some
samples from the pregnancy visits and post-partum visit
being analysed at the same time, therefore reducing the
likelihood of bias resulting from differences in timing of
analyses.
Personal and indoor air naphthalene concentrations
collected during pregnancy were highly correlated, within
each visit and across visits with Spearman Correlation
Coefficients ranging from 0.83 to 0.91 (p-value = <.0001).
The average of the two pregnancy measures and the post-
partum concentrations were also significantly correlated,
personal r = 0.4 (p-value = 0.0026) and indoor r = 0.46
(p-value = 0.0004).
Significant correlations were observed in the urinary
SG-adjusted 2-naphthol concentration in samples col-
lected during pregnancy on weekdays and the weekend
(r = 0.78, p < 0.001) and when comparing pregnancy and
postpartum samples (r = 0.54, p < 0.001). There were no
significant correlations seen with the postpartum breast
milk samples with any of the air or urine measures.
The ICC analysis suggested moderate reproducibility for
SG-adjusted 2-naphthol across the study period (weekday,
weekend and post-partum samples) (ICC = 0.66). The
ICCs were low for indoor air (ICC = 0.31), personal air
(0.32) and 1-naphthol (0.24).
Simple linear regression models examined associations
between various naphthalene sources (e.g., moth ball use,
exposure to smoke, attached garage, density of roads and
highways in neighbourhood, presence of a wood-burning
fireplace, type of ventilation and heating in the home) and
measured concentrations of naphthalene in air and
biomarkers; no significant associations were found (all
p-values greater than 0.05, see Additional file 1: Table S1).
Similarly, no consistent associations were seen with age
or BMI. The data suggested that samples collected dur-
ing the winter had lower indoor and personal air naph-
thalene concentrations compared to summer. This was
significant at the 0.05 level for indoor air concentrations
post-partum, and for personal air concentrations during
pregnancy on both sampling days (see Table 3). The
weekday 2-napthol concentrations were significantly
different in the fall and winter compared to the summer.
We did observe a small association between urinary 1-
naphthol concentrations and naphthalene in breast milk
despite there being no correlations: a 10% increase in 1-
naphthol in urine was associated with a 1.6% increase in
naphthalene in breast milk (95% CI: 0.2% - 3.1%). Two
observations were removed from this analysis due to
their high influence on the association, as indicated by
Cook’s distance.
There were 4 women in the pregnancy period and
2 women in the post-birth period with 1-naphthol to
2-naphthol ratios above 2 which could be indicative
of exposure to carbaryl as opposed to naphthalene.
Excluding these individuals from the simple linear regres-
sion models did not change the results, with the exception
of the association between urinary 1-naphthol and naph-
thalene in breast milk; this association was reduced to a
1.1% (95% CI: −0.3% - 2.6%) increase in naphthalene with
a 10% increase in 1-naphthol. This association should be
interpreted with caution due to the small sample size mea-
sured, and the fact that the association was reduced when
we removed individuals suspected of having alternative
sources of 1-naphthol.
Discussion
The measured indoor air concentrations of naphthalene
(medians across the 3 sampling periods ranging from
0.68 to 1.83 μg/m3) are comparable to findings from pre-
vious studies. Jia and Batterman [9] summarized residen-
tial indoor air naphthalene concentrations for studies
conducted from 1986 to 2006. The authors reported a
median concentration range for homes without smokers
of 0.18 to 1.7 μg/m3. Only one indoor air measurement
from the three monitoring sessions in this study was
found to be above the Health Canada guideline of
10 μg/m3 [4] at 11.71 μg/m3. This measurement was
taken at the post-birth visit; the source for this higher
level was not clear but the pregnancy-period measure-
ment at the same home was well below the guideline
(3.03 μg/m3) suggesting that this was not the result of
an ongoing source.
Canadian levels of indoor air naphthalene have been
measured in several studies. The median naphthalene level
in Quebec City homes without smokers was 1.12 μg/m3
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Table 2 Descriptive statistics of measured naphthalene and metabolite concentrations in environmental and biological samples in the P4 Study
Sample Pregnancy - weekday Pregnancy - weekend Weekday
vs weekend
day
2-3 months post-birth Pregnancy
vs.
post-birth
N Q1 Median Q3 GM
(GSD)
95th%
ile
Min – Max N Q1 Median Q3 GM
(GSD)
95th%
ile
Min – Max Sign rank
test
N Q1 Median Q3 GM
(GSD)
95th%
ile
Min – Max Sign rank
test
Air (μg/m3)
Personal 56 0.38 0.73 1.03 0.7
(2.18)
3.14 0.2 –6.37 58 0.37 0.79 1.21 0.79
(2.41)
3.9 0.2 - 14.85 0.10 61 1.09 1.74 2.46 1.68
(1.86)
4.51 0.3 - 12.31 <0.0001
Indoor 57 0.5 0.68 1.06 0.8
(2.01)
3.51 0.27 –5.97 58 0.45 0.73 1.05 0.76
(2.05)
3.56 0.22 -4.79 0.55 60 1.14 1.83 2.48 1.79
(1.82)
4.94 0.31 - 11.71 <0.0001
Urine (μg/L)
1-naphthol 62 0.73 1.14 2.28 1.32
(2.80)
6.06 0.13 - 126.08 67 0.67 1.05 1.91 1.16
(2.44)
3.85 0.23 - 81.57 62 0.65 1.06 1.62 1.04
(2.69)
6.16 0.14 - 11.62
1-naphthol –
SG* corrected
62 0.7 1.19 2.22 1.34
(2.72)
6.3 0.2 - 140.7 67 0.78 1.15 1.74 1.23
(2.41)
3.68 0.22 -133.4 0.34 62 0.73 1.09 1.67 1.23
(2.08)
4.46 0.38 - 12.48 0.4
2-naphthol 62 1.7 2.73 5.09 2.92
(2.08)
9.57 0.81 -16.41 67 1.72 2.56 4.29 2.72
(2.14)
12.4 0.68 - 19.93 62 1.56 2.86 5.85 2.86
(2.86)
13.47 0.19 - 32.8
2-naphthol –
SG* corrected
62 1.73 2.53 4.7 2.94
(1.99)
9.47 0.87 - 14.43 67 1.97 2.84 3.95 2.92
(1.93)
11.56 0.77 - 17.53 0.44 62 2.09 3.33 5.66 3.39
(2.16)
12.19 0.74 - 25.39 0.15
Breast Milk (ng/g lipid)
Naphthalene N/A 52 6.06 7.55 13.05 9.12
(1.92)
40.17 3.86 – 79.36 N/A
*Specific gravity.
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for a seven day integrated sample [40]. Measurements
made in a population-based study of Canadian homes in
1991 over multiple seasons had a range of 24-hour mean
concentrations of 1.10 – 8.10 μg/m3 [41]. An Ottawa
based study of 75 residences had a 24-hour mean of
3.87 μg/m3. These studies included both homes with and
without smokers [42]. Indoor air naphthalene was also
measured in homes without smokers in Edmonton, Al-
berta, where 7-day median concentrations were 0.32 and
0.29 μg/m3, for winter and summer seasons respectively
[43]. This contrasts with our findings where summer in-
door concentrations were significantly higher than both
fall and winter. The sampling time frame for the different
studies may explain some of the differences in concentra-
tions of naphthalene in indoor air.
Very little data exists on personal monitoring for
naphthalene exposure; however, the concentrations we
measured among pregnant women (medians ranging
from 0.73 to 1.74 μg/m3) are slightly lower than concen-
trations found in other populations. An Italian study of
non-occupationally exposed adults living and working in
Milan and the surrounding areas included 108 subjects,
18 of whom completed both personal air sampling and
urine samples which were analysed for naphthalene. Me-
dian personal naphthalene air samples taken during the
5-hour work period was 3.4 μg/m3 (interquartile range:
1.4 – 4.9 μg/m3), with no differences between smokers
and non-smokers. They also measured concentrations of
un-metabolized naphthalene in urine (median: 46 ng/L,
interquartile range: 41 – 56 ng/L) but found no associations
between the personal air and urine naphthalene concen-
trations. They were also unable to identify any predictors
for either the air or urine samples [44].
In an Atlanta, GA-based study of 8 non-occupationally
exposed individuals who completed a personal air sam-
ple along with urine samples, median exposure levels to
naphthalene ranged from a low of 0.13 μg/m3 at work
(interquartile range: 0.095–0.22 μg/m3) to a high of
0.92 μg/m3 indoors at home (interquartile range: 0.37–
3.27 μg/m3). Indoor home concentrations were higher
than concentrations measured while driving, which reflect
the importance of residential indoor sources for naphtha-
lene. A comparison of personal air measurements and
urinary excretion of naphthalene between days with high
and low PAH diets suggested that inhalation is the pri-
mary route of exposure for naphthalene [14].
The study by Bouchard et al., [45] asked participants
to record habits and activities involving potential PAH
exposures. They were only able to identify passive smoking
with exposure associated with higher 2-naphthol excretion.
The authors felt that the absence of a link between most
of the variables from the questionnaire and the urinary ex-
cretion of PAH biomarkers was due to the low reporting
of exposure to these variables.
Indoor air measurements of naphthalene have previ-
ously been recognized to be a good proxy for personal
naphthalene air exposures [46]. The high correlations we
observed between indoor and personal naphthalene con-
centrations confirm this, see Additional file 2: Figure S1.
There are a number of sources of naphthalene in the in-
door environment, including moth balls and deodorizers,
smoking, attached garages, construction and wood prod-
ucts, indoor combustion, and heating systems [9,47]. Al-
though we examined a number of known indoor sources,
we were unable to confirm associations with measured in-
door and personal concentrations, as has been the case for
previous studies [45,46], (see Additional file 1: Table S1 for
the univariate analyses). Moth balls are available with two
different formulations in Canada (para-dichlorobenzene
or naphthalene) and we did not collect data on which type
our study participants used therefore limiting our ability
to interpret the influence of this particular source. In a lar-
ger study of 288 homes in Michigan, Batterman et al. [8]
identified pest repellant use, presence of an attached gar-
age, cigarette smoke, and outdoor sources as contributing
to indoor naphthalene concentrations. This may indicate
that for many homes, the total naphthalene level reflects a
number of smaller sources and cannot easily be attributed
to distinct sources without significant statistical power. An
exception is the improper use of moth balls, which can be
associated with extremely high indoor concentrations of
naphthalene [48]. Only 4 homes in the current study re-
ported using moth balls, and they did not have elevated
indoor naphthalene concentrations. Health Canada’s Pest
Table 3 Seasonal simple linear regression results for
naphthalene in air (μg/m3)
Exposure Season N Median Mean GM p-value*
Weekday Indoor
Fall 19 0.947 1.254 1.029 0.341
Spring 13 0.827 1.349 0.903 0.728
Summer 15 0.780 1.005 0.827
Winter 15 0.489 0.626 0.524 0.063
Post-Partum Indoor
Fall 9 1.024 1.532 1.258 0.006
Spring 22 1.798 1.923 1.815 0.074
Summer 8 2.355 3.164 2.781
Winter 19 1.849 2.223 1.639 0.031
Weekday Personal
Fall 20 0.950 1.423 1.083 0.583
Spring 13 0.801 1.156 0.840 0.695
Summer 15 0.734 1.449 0.940
Winter 13 0.295 0.477 0.338 0.001
Post-Partum Personal
Fall 9 1.023 1.183 1.153 0.002
Spring 22 1.739 1.742 1.665 0.031
Summer 8 2.501 3.219 2.819
Winter 20 1.556 2.236 1.538 0.015
*Simple Linear Regression with Summer as the reference category.
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Management Regulatory Agency re-evaluated naphthalene
pest-control products in 2010 and concluded that they do
not present unacceptable risks to human health when
used according to label directions. In this study, there
were also a limited number of smokers and exposure to
SHS was also limited so it was not possible to evaluate the
impact of smoking as a source of naphthalene.
We observed that indoor and personal naphthalene
concentrations in air were significantly higher at the
post-birth visit than the two pre-birth visits. This may be
a result of new products being introduced into the home
during this period, as well as possible home renovations.
Consumer product uses of naphthalene include some
commercially available coatings and paints. As we did not
specifically ask about these, we are unable to confirm this
hypothesis.
Monitoring was quite evenly distributed throughout
the year; some seasonality was seen for the indoor air
concentrations but not for the biomarkers. In studies in
California there was evidence that PAH concentrations
increased as temperatures decreased. However, this
trend in seasonality was most pronounced for particle
phase PAHs. Vapour phase PAHs (i.e., 99% of naphtha-
lene) did not demonstrate any dramatic seasonality [49].
Naphthalene data collected in the Halifax and Edmonton
indoor air studies conducted by Health Canada demon-
strated that homes sampled during both the winter and
summer had similar concentrations to one another [37,43].
The urinary results for this study indicated that there
were no significant differences between the three visits
with the medians across the 3 sampling periods, ranging
from 1.05 to 1.14 for 1-naphthol and 2.56 to 2.86 μg/l
for 2-naphthol. The results are similar to those identified
by Bouchard et al., [45] where the geometric mean urin-
ary concentrations of 1-naphthol in first morning voids
varied from 0.99 to 1.23 μmol/mol creatinine over an 8-
month period; the corresponding figures for 2-naphthol
were 1.37 to 2.39 μmol/mol creatinine. This indicates
that there are some small differences in concentrations by
urine collection days which may be lost in our sampling ap-
proach of using 24-hour samples in the pregnancy period.
Our results for 1-naphthol are also comparable with those
from another pregnancy cohort study and with population-
based Canadian data, but lower than the Canadian data for
2-naphthol. In the CHAMACOS study of pregnant women
in California, the median 1st trimester urinary concentra-
tions of 1- and 2-naphthol were 1.9 and 1.7 μg/L, respect-
ively [39]. For females 20–39 in the Canadian Health
Measures Survey (2009–2011), the median 1- and 2-
naphthol concentrations in urine (measured by the same
laboratory as this study) were 1.2 and 5.4 μg/L, respect-
ively [50], (Figure 1).
Median concentrations of naphthalene in breast milk
were significantly lower than observed in previous stud-
ies at 7.55 ng/g lipid. The study by Tsang et al. [18] in
Hong Kong showed mean naphthalene concentrations of
786 ng/g lipid in breast milk. The researchers found a
positive correlation between PAH concentrations in milk
and maternal age; our study was unable to reproduce
this result. The Turkish study of Çok et al., [19] found
that naphthalene was one of the most abundant PAH
(contributing 42.6% to the total PAH) identified in human
milk from 47 women (mean = 45.75 ng/g lipid). When
they separated the analyses by smoking status some of the
non-smoking mothers did not have detectable naphtha-
lene concentrations. Similarly, Zanieri et al., [20] found
that human milk derived from non-smoking women had
approximately half the concentrations of naphthalene
compared to smokers (5.56 vs. 10.54 μg/kg of fresh weight
milk). The participants in our study were overwhelmingly
non-smokers (97%), which may contribute to their low
naphthalene concentrations.
Limitations of this study include the relatively small
sample size measured and the lack of detailed information
Figure 1 Median urinary concentrations of 1- and 2-naphthol from the CHAMACOS 1st and 2nd prenatal samples [39], NHANES
pregnant women [39], the Canadian Health Measures Survey (CHMS) (females 20 – 39 years of age) [50] and our P4 Study.
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on possible indoor sources including the use of deodor-
izers, sanitizers and air fresheners. Another limitation of
the low recruitment rate is the ability to generalise the
findings to other pregnant women and populations.
Methods for measuring naphthalene in air may be inferior
compared to other volatile organic compounds (VOCs)
due to methodological limitations (e.g., recovery and re-
producibility) [51] although this may be less problematic
as the analytical approach used in this study included a
naphthalene specific extraction to ensure maximum re-
covery [37]. In general, very few studies have attempted to
identify predictors of naphthalene concentrations in in-
door air. The studies that did examine predictors found
that indoor naphthalene concentrations were positively
and significantly associated with the presence of forced
air heating systems with filtration [40], attached garages
[40,52], bathroom cleaners/deodorizers [53], and moth
control products [9,54].
This study provides valuable information on personal
exposure to naphthalene as measured in air, urine and
breast milk in the prenatal and post-natal windows. Sus-
pected naphthalene transfer across the placenta has been
documented in case studies at high maternal exposure
concentrations, with the fetus apparently more vulner-
able to naphthalene toxicity than the mother [22,23]. In
a pilot study conducted in California, 70% of the amni-
otic fluids tested positive for 1- or 2-naphthol indicating
direct exposure of the young fetus to these phenols;
however as the authors did not distinguish between the
two metabolites and the study was conducted in an agri-
cultural area, exposure to carbaryl as opposed to naphtha-
lene cannot be ruled out [55]. Since the rate of metabolism
of naphthalene in humans is not well characterized, infor-
mation on the urinary biomarker concentrations may be
useful for future attempts to characterize the rate of me-
tabolism in humans in general, or in specific populations
(e.g., pregnant women). One possible reason for the lack of
association between the biomarkers and the indoor and
personal air samples may be the different excretion rates
identified by Heikkila et al., [16]. They also found that in
workers exposed to occupational concentrations of naph-
thalene that there were poor associations between air con-
centrations and the urinary metabolite 1-naphthol with
correlation coefficients less than 0.5. Kuusimaki et al., [13]
also failed to observe any associations between air samples
and urinary metabolites which they attributed to the fact
that the workers’ exposures were a combination of diet
and occupational exposures. The lack of association be-
tween air concentrations and urinary metabolite concen-
trations could also be due to genetic differences. P450
isoform screening of naphthalene metabolism, performed
with human P450 isoforms expressed in baculovirus-
infected insect cells, identified CYP1A2 as the most effi-
cient isoform for producing dihydrodiol and 1-naphthol,
and CYP3A4 as the most effective for 2-naphthol produc-
tion [56]. Genetic variations in these enzymes as well as
those involved in forming naphthol conjugates (SULT1A1
and UGT1A9) could lead to differences in biotransform-
ation capacity among participants [57,58].
Conclusions
The results from this study suggest that indoor air moni-
toring of naphthalene provides a good indication of per-
sonal air exposures for pregnant women. Potential sources
of biomarker concentrations of naphthalene could not be
identified, which is consistent with several other studies.
While urinary 1-naphthol and naphthalene in breast milk
were associated there were no other associations found for
the personal and indoor air concentrations and bio-
markers. Potential reasons for this include a potential lack
of significant sources, physiological (excretion rates) and
behavioural differences that were not captured.
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